Associated Papers
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
33424349 (PubMed )
Supplement: mmc1.xlsx › Sheet1
Analysis of CYP2J2 mutations in the Chinese Uyghur population.
Li H et al.
American Journal of Translational Research, 2021
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
31159795 (PubMed )
Supplement: 12920_2019_527_MOESM1_ESM.xlsx › Table_S6
Genetic polymorphisms of the drug-metabolizing enzyme CYP2J2 in a Tibetan population.
Cao P et al.
Medicine, 2018
Genetic polymorphisms of CYP2S1, CYP2J2 and CYP2R1 genes in three Chinese populations: Han, Tibetan and Uighur.
Kang X et al.
Pharmacogenomics, 2018
Pharmacogenetic Variation in Over 100 Genes in Patients Receiving Acenocumarol.
Gonzalez-Covarrubias V et al.
Frontiers in Pharmacology, 2017
29218011 (PubMed )
Supplement: Table1.XLSX › ST1_targetgenes
Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations.
Yamazaki H et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 2006
Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.
Lee SS et al.
Pharmacogenetics and Genomics, 2005
Select a paper to view details